Multiple Sclerosis Treatment

Shiva Gopal Vasishta is a licensed doctor in New Jersey who practices neurology and psychiatry at the Eastern Neurodiagnostic Associates he also works closely with Kennedy Health System Cherry Hill Campus. He studied and graduated with a medical degree from the government medical college in 1979. He undertook a medical resident program at Boston University medical center and is now among the 34 doctors at Kennedy University Hospital who specialize in neurology.

In his more than 30 years of practice, Dr. Shiva Gopal Vasishta has gained expansive knowledge on neurological, nervous system and other disorders that affect the brain, spinal cord, peripheral nerves, and muscles. He also treats diseases associated with the involuntary nervous system that controls the brain and some muscular organs such as the heart and lungs. In addition to treating these diseases, he treats other general illnesses such as headaches, seizures, stroke, and epilepsy, sleep disorders and multiple sclerosis among others.

Most recently a research in multiple sclerosis (MS) treatment shows that the MS drugs in the market have a lower curative efficiency that they are thought to have. The research shows that a one-time treatment with a high-dose immunosuppressive therapy and autologous hematopoietic cell transplant is more effective that the long-term treatment with MS drugs. The body’s immunity was suppressed after the collection of the patient’s stem cells that were later injected into the body after the treatment. The body’s immunity was suppressed after the collection of the patient’s stem cells that were later injected into the body after the treatment. Even though a few of the patients showed no improvements most of the patients shown progress, their relapsing-remitting multiple sclerosis remained in remission in the five years and some of them regained some of the lost abilities.

The research funded by the National Institute of Allergy and Infectious Diseases is hope that there could be the better treatment for the drug-resistant multiple sclerosis that has made many people lose hope. Eventually, the research’s findings need further research but it is a good to start when it comes to better treatment and diagnosis of the disease.